Cited by — Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer’s disease: randomised, controlled trial | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer’s disease: randomised, controlled trial.
No admitted local citation edges point to this work yet.
